Mitochondrial permeability transition pore (MPTP) (MPTP)

The mitochondrial permeability transition pore (MPTP) is a high-conductance, non-specific channel that forms across the mitochondrial membranes in response to cellular stressors such as calcium overload, oxidative stress, and ATP depletion. Its opening triggers the "mitochondrial permeability transition" (MPT), a critical event characterized by the sudden loss of the inner mitochondrial membrane's selective permeability, leading to the dissipation of the membrane potential and mitochondrial swelling. This swelling often results in the physical rupture of the mitochondrial outer membrane bilayer, releasing pro-apoptotic proteins like cytochrome c into the cytoplasm and initiating cell death pathways via apoptosis or necrosis. The MPTP is a significant therapeutic target in conditions involving acute tissue injury, such as myocardial infarction and stroke, as well as in chronic neurodegenerative diseases like Alzheimer's and Parkinson's. Pharmacological intervention typically involves the use of inhibitors like Cyclosporine A and its non-immunosuppressive analogs, which bind to the regulatory protein Cyclophilin D to prevent pore opening and preserve mitochondrial function. Additionally, the role of the membrane bilayer composition, particularly the phospholipid cardiolipin, is increasingly recognized as a vital factor in the assembly and regulation of the pore complex.

Other names

mPTPMPT poreMitochondrial megachannelPermeability transition pore complexPTPMitochondrial outer membrane permeability transition poreMitochondrial outer membrane – permeability transition / membrane bilayer

Inhibition of pore opening by binding to Cyclophilin D (CypD); modulation of the Adenine Nucleotide Translocator (ANT) and Voltage-Dependent Anion Channel (VDAC); stabilization of the mitochondrial membrane bilayer and cardiolipin interactions to prevent membrane permeabilization.